Skip to main content
Moderna, Inc. logo

Moderna, Inc. — Investor Relations & Filings

Ticker · MRNA ISIN · US60770K1079 LEI · 549300EI6OKH5K5Q2G38 US Manufacturing
Open in API
Filings indexed 1,397 across all filing types
Latest filing 2021-02-25 Director's Dealing
Country US United States of America
Listing US MRNA

About Moderna, Inc.

https://www.modernatx.com/

Moderna, Inc. is a biotechnology company pioneering the development of messenger RNA (mRNA) therapeutics and vaccines. The company's core platform utilizes mRNA to carry instructions that direct the body's cells to produce proteins, thereby preventing or treating diseases. This technology enables the rapid design, research, and production of new medicines. Moderna is widely recognized for developing one of the first COVID-19 vaccines. Its research and development pipeline extends to various therapeutic areas, including infectious diseases, immuno-oncology, rare diseases, and autoimmune disorders. The company's mission is to create a new generation of transformative medicines for patients by leveraging the potential of its mRNA platform.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2021-02-25 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC by Moderna, Inc. dated February 25, 2021. It announces the results of operations and financial condition for the fourth quarter and year ended December 31, 2020, referencing a press release (Exhibit 99.1) that contains the actual financial results. The text explicitly states that the Form 8-K and the press release are furnished and not filed, and the document itself is a current report rather than the full financial report. The document length is 3479 characters, which is relatively short and mainly serves as an announcement of the earnings release rather than containing detailed financial statements or analysis. According to the rules, initial announcements of quarterly or periodical financial results (key highlights only) correspond to the Earnings Release (ER) category. Therefore, this document should be classified as an Earnings Release (ER).
2021-02-25 English
FORM 4 SUBMISSION
Director's Dealing
2021-02-25 English
FORM 4 SUBMISSION
Director's Dealing
2021-02-25 English
PRIMARY DOCUMENT
Director's Dealing
2021-02-24 English
PRIMARY DOCUMENT
Director's Dealing
2021-02-24 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.